Using magnets to release proteins for spinal cord injury recovery
Magnetically Triggered Protein Release for Varying Severities of Spinal Cord Injury
This study is exploring a new way to help people recover from spinal cord injuries by using special fibers that can release healing substances when exposed to a magnetic field, making treatments more personalized and effective.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rensselaer Polytechnic Institute NIH-funded |
| Lab location | 1 site (Troy, United States) |
| Project ID | NIH-10984638 on NIH RePORTER |
What this research studies
This research focuses on developing innovative drug delivery systems that use magnetically responsive fibers to enhance recovery after spinal cord injuries. By creating electrospun fibers loaded with growth factors, the team aims to control the release of these therapeutic agents in response to a magnetic field, allowing for tailored treatment based on individual patient needs. This approach addresses the variability in inflammation that occurs after spinal cord injuries, which can affect recovery outcomes. The goal is to improve regeneration of damaged spinal cord tissues and promote healing.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced spinal cord injuries of varying severities.
Not a fit: Patients with spinal cord injuries that are too severe or those who are not eligible for experimental treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for spinal cord injuries, potentially improving recovery and quality of life for patients.
How similar studies have performed: Previous research has shown promise in using biomaterials for drug delivery in spinal cord injuries, but this specific approach using magnetic stimulation is relatively novel.
Where this research is happening
Troy, United States
- Rensselaer Polytechnic Institute — Troy, United States (Active)
Researchers
- Principal investigator: Gilbert, Ryan J. — Rensselaer Polytechnic Institute
- Study coordinator: Gilbert, Ryan J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.